Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Studies on HRT for breast cancer patients can give false hopes

19.05.2005


Women treated for breast cancer who are considering taking Hormone Replacement Therapy (HRT) should be cautious when using published research to inform their decision. An article published today in the journal Breast Cancer Research reveals that qualitative studies on the recurrence of breast cancer in breast cancer survivors undergoing HRT are unreliable.



There are two main types of research studies – qualitative and quantitative. Each type is used to answer different research questions. Dr Col, from Brown Medical School, USA, and colleagues found that all of the qualitative studies on the recurrence of breast cancer in patients taking HRT they looked at have “serious design features that could introduce selection, reporting and/or publication biases”.

These qualitative studies have concluded that there is no increased risk of the recurrence of breast cancer in patients taking HRT, but the authors of today’s study feel that this is not a reliable conclusion. Meanwhile, evidence from randomized controlled trials - a type of quantitative study – suggests the opposite – that there is an increased risk of the recurrence of breast cancer in patients taking HRT.


Patients and doctors, the authors conclude, should base their decision on randomised controlled trials, as these “provide the only reliable estimates of recurrence risk”.

The authors scrutinized 10 studies on the recurrence of breast cancer in a total of 1,316 breast cancer survivors who used HRT and 2,839 who didn’t. Out of the ten studies, the eight qualitative studies were positive and suggested that HRT decreases the risk of breast cancer recurrence by 0.64. The two randomised controlled trials found the opposite and concluded that HRT increases the risk of recurrence by 3.41.

The positive studies were all said to have methodological limitations that could not be controlled using statistical methods. For example, they selected healthier women to take HRT and followed them for only a very short time. The authors also speculated that ‘publication bias’ played a role – this is where researchers and journals are more likely to publish positive results, which suggests that negative results have not been published. Overall, this bias in the reporting of results has propagated the idea of a protective effect of HRT.

Overall, the authors conclude that these qualitative studies “should be considered essentially uninformative with respect to HRT use in breast cancer survivors.”

Women who have been treated for breast cancer are usually menopausal, either because of age, the cancer itself or because of therapy. HRT offers the hope of overcoming symptoms of the menopause such as hot flushes, mood swings and increased risk of developing osteoporosis. The link between HRT and breast cancer is controversial. The present study highlights the need for extreme caution and critical judgment when looking at the evidence for or against HRT use in breast cancer survivors.

Juliette Savin | alfa
Further information:
http://www.biomedcentral.com

More articles from Health and Medicine:

nachricht Cystic fibrosis alters the structure of mucus in airways
28.06.2017 | University of Iowa Health Care

nachricht Mice provide insight into genetics of autism spectrum disorders
28.06.2017 | University of California - Davis

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Supersensitive through quantum entanglement

28.06.2017 | Physics and Astronomy

X-ray photoelectron spectroscopy under real ambient pressure conditions

28.06.2017 | Physics and Astronomy

Mice provide insight into genetics of autism spectrum disorders

28.06.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>